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Abstract 
Purpose: Much of the common practice in paediatric mechanical ventilation is based on personal experiences and 
what paediatric critical care practitioners have adopted from adult and neonatal experience. This presents a barrier 
to planning and interpretation of clinical trials on the use of specific and targeted interventions. We aim to establish a 
European consensus guideline on mechanical ventilation of critically children.
Methods: The European Society for Paediatric and Neonatal Intensive Care initiated a consensus conference of 
international European experts in paediatric mechanical ventilation to provide recommendations using the Research 
and Development/University of California, Los Angeles, appropriateness method. An electronic literature search in 
PubMed and EMBASE was performed using a combination of medical subject heading terms and text words related 
to mechanical ventilation and disease‑specific terms.
Results: The Paediatric Mechanical Ventilation Consensus Conference (PEMVECC) consisted of a panel of 15 experts 
who developed and voted on 152 recommendations related to the following topics: (1) general recommendations, 
(2) monitoring, (3) targets of oxygenation and ventilation, (4) supportive measures, (5) weaning and extubation readi‑
ness, (6) normal lungs, (7) obstructive diseases, (8) restrictive diseases, (9) mixed diseases, (10) chronically ventilated 
*Correspondence:  m.c.j.kneyber@umcg.nl 
1 Department of Paediatrics, Division of Paediatric Critical Care 
Medicine, Beatrix Children’s Hospital Groningen, University Medical 
Center Groningen, The University of Groningen, P.O. Box 30.001, 9700 
RB Groningen, The Netherlands
Full author information is available at the end of the article
Take-home message: Much of the common practice in paediatric 
mechanical ventilation is based on personal experiences and 
what paediatric critical care practitioners have adopted from adult 
and neonatal experience. This presents a barrier to planning and 
interpretation of clinical trials on the use of specific and targeted 
interventions. The PEMVECC guidelines should help to harmonise the 
approach to paediatric mechanical ventilation and thereby propose a 
standard‑of‑care applicable in daily clinical practice and clinical research.
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Introduction
Huge variability in size, lung maturity and the range of 
acute and chronic diagnoses have contributed to a lack 
of clinical evidence supporting the daily practice of pae-
diatric mechanical ventilation (MV) (Fig.  1) [1, 2]. This 
prompted the Respiratory Failure Section of the Euro-
pean Society for Paediatric and Neonatal Intensive Care 
(ESPNIC) to convene the paediatric mechanical ven-
tilation consensus conference (PEMVECC), aiming to 
harmonise the approach to paediatric MV and define a 
standard-of-care applicable in clinical practice and future 
collaborative clinical research. Specific aims were to pro-
vide recommendations regarding ventilation modali-
ties, monitoring, targets of oxygenation and ventilation, 
supportive measures, and weaning and extubation readi-
ness for patients with normal lungs, obstructive airway 
diseases, restrictive diseases, mixed diseases and chroni-
cally ventilated patients, cardiac patients and lung hypo-
plasia syndromes, and to provide directions for further 
research. From 138 recommendations drafted, 34 (32.7%) 
did not reach “strong agreement” and were redrafted (i.e. 
rewriting or rephrasing sometimes into two different rec-
ommendations), resulting in 52 recommendations for 
the second voting round. Of these, 142 (93.4%) reached 
“strong agreement”.
Methods
The steering committee (M.K. (chair), D.d.L., J.B., P.B. and 
P.R.) defined disease conditions (see ESM) and identified 
ten European panel members who were internation-
ally established paediatric MV investigators with recent 
peer-reviewed publications (last 10 years). An electronic 
literature search in PubMed and EMBASE (inception 
to September 1, 2015) was performed using a combina-
tion of medical subject heading terms, text words related 
to MV and disease-specific terms. All panel members 
screened the references for eligibility, defined by (1) age 
<18  years, (2) describing non-invasive or invasive res-
piratory support, and (3) type of design (i.e. any type of 
clinical study except for case-series and reports). Publica-
tions were excluded if they described diseases exclusively 
linked to the perinatal period. The proposal by Chatburn 
(ESM, Table 2) was used for ventilator taxonomy [3, 4].
Recommendations were drafted by all panel mem-
bers, and subsequently discussed at a two-day meet-
ing in Rome, Italy (September 2015). This resulted in a 
final set of recommendations, subjected to electronic 
voting (December 2015) using the Research and Devel-
opment/University of California, Los Angeles (RAND/
UCLA) appropriateness method scale [5]. Recommen-
dations were scored from 1 (complete disagreement) to 
9 (complete agreement). Median score (95% confidence 
interval) was calculated after eliminating one lowest and 
highest value. Recommendations were labelled “strong 
agreement” (median 7–9 and no score <7), “equipoise” 
(median 4–6) or “disagreement” (median 1–3). Recom-
mendations without “strong agreement” were rephrased. 
Revised recommendations retaining “strong agreement” 
after the second electronic voting (February 2016) were 
patients, (11) cardiac patients and (12) lung hypoplasia syndromes. There were 142 (93.4%) recommendations with 
“strong agreement”. The final iteration of the recommendations had none with equipoise or disagreement.
Conclusions: These recommendations should help to harmonise the approach to paediatric mechanical ventilation 
and can be proposed as a standard‑of‑care applicable in daily clinical practice and clinical research.
Keywords: Mechanical ventilation, Physiology, Paediatrics, Lung disease










































Disease trajectory (getting better)
Fig. 1 Graphical simplification of the gaps in knowledge regarding 
paediatric mechanical ventilation as a function of disease trajectory 
when the patient is getting worse or is getting better
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labelled “weak agreement” and the percentage of agree-
ment (number of individual scores ≥7 divided by 15) 
quantified the level of disagreement. As it was expected 
a priori that there would be very few RCTs or system-
atic reviews, it was decided by the steering committee to 
keep the consensus guideline descriptive and not use the 
GRADE system [6].
Non-invasive support
High‑flow nasal cannula (HFNC) and continuous positive 
airway pressure (CPAP)
There is insufficient data to recommend on the use of 
HFNC in obstructive airway (strong agreement), restric-
tive (strong agreement) or mixed disease (strong agree-
ment) or on the use CPAP in obstructive airway (strong 
agreement) or restrictive disease (93% agreement). CPAP 
may be considered if there are no contra-indications 
(strong agreement) as initial support in mixed disease 
(strong agreement) and mild-to-moderate cardiorespira-
tory failure (strong agreement). There is insufficient data 
to recommend on the optimal interface for CPAP (strong 
agreement).
Although HFNC or CPAP may reduce the work of 
breathing, there are no outcome data showing superior-
ity of HFNC or CPAP over any other intervention [7–28].
Non‑invasive ventilation (NIV)
NIV can be considered before resorting to intubation 
in obstructive airway (strong agreement), restrictive 
disease (93% agreement), mild-to-moderate PARDS 
(strong agreement) or cardiorespiratory failure (strong 
agreement). NIV should not delay endotracheal intuba-
tion, but no specific limits can be provided in any dis-
ease condition (strong agreement). There are no data to 
recommend on any method or timing of NIV (strong 
agreement). There are insufficient data to provide rec-
ommendations on the optimal interface for NIV. Any 
interface with the least leakage needs to be used (strong 
agreement). Dependent on local experiences and mate-
rials, full face mask, oral-nasal mask or helmet for NIV 
should be used (93% agreement).
Non-invasive ventilation (NIV) is increasingly being 
used in ARF [29–32], after cardiac surgery for congeni-
tal heart disease [33–36], status asthmaticus [37, 38], or 
neuromuscular patients with ARF [39–41]. Few uncon-
trolled studies suggested improved extubation success 
with NIV [42, 43]. Two RCTs comparing NIV versus 
oxygen supplementation on intubation prevention pro-
duced opposing results [43, 44]. In adult studies, NIV 
increased adverse outcomes in severe ARDS [45–52]. 
To avoid delayed intubation, success of NIV should be 
assessed already 1  h after initiation by observing heart 
and respiratory rate,  SpO2/FiO2 ratio, pH, level of con-
sciousness and presence of organ failure [44, 50, 53].
Ventilator modes
We cannot make recommendations on any mode of 
mechanical ventilation for children with normal lungs 
(strong agreement), obstructive airway (strong agree-
ment), restrictive (strong agreement), mixed disease 
(strong agreement), chronically ventilated children 
(strong agreement), cardiac children (strong agreement) 
or children with lung hypoplasia (strong agreement). 
With restored respiratory drive, pressure support ventila-
tion may be considered. If used, the sensitivity of the flow 
cycling and rise time should be set to obtain an appro-
priate inspiratory time (strong agreement). There are no 
outcome data to recommend on closed-loop ventilation 
(strong agreement).
There are no outcome data to recommend on any ven-
tilatory or respiratory assist modes for children with or 
without lung pathology, cardiac children, or chronically 
ventilated children requiring escalation of support for 
acute exacerbations [2, 54–59]. Ventilator mode should 
be dictated by clinical experience and theoretical argu-
ments, considering the pathophysiology of the disease 
[60, 61].
There are insufficient data to recommend on high-
frequency oscillatory ventilation (HFOV) in obstructive 
airway (strong agreement), restrictive (strong agree-
ment), mixed disease (strong agreement), cardiac chil-
dren (strong agreement), chronically ventilated children 
or children with a congenital disorder who suffer from 
an acute exacerbation (93% agreement). HFOV may be 
considered if conventional ventilation fails (strong agree-
ment), using an open lung strategy to maintain optimal 
lung volume. Careful use of HFOV can be considered in 
cardiac children who developed severe respiratory fail-
ure. Particular caution is advised in children with passive 
pulmonary blood flow or right ventricular dysfunction 
(strong agreement).
A mortality benefit of HFOV in acute hypoxaemic res-
piratory failure (AHRF) has not been shown [62]. Recent 
retrospective cohort analyses seemed to confirm adult 
observations of even an increased mortality with HFOV, 
although major methodological issues have been raised 
regarding these studies [63–71]. HFOV can judiciously 
be performed in obstructive airway disease and car-
diac children, including those with a Fontan circulation 
[72–78].
There are insufficient data to recommend on high-
frequency jet or high-frequency percussive ventila-
tion (strong agreement) or airway pressure release 
ventilation (strong agreement). HFJV should not be 
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used in obstructive airway disease because of the risk of 
dynamic hyperinflation (strong agreement).
There are no outcome data supporting high—frequency 
jet (HFJV) or high—frequency percussive ventilation 
(HFPV) for any disease condition outside the operating 
theatre when managing children with airway disorders 
[79–85].
We recommend considering extra-corporeal devices 
(ECMO or other devices) where available in reversible 
diseases if conventional and/or HFOV fails. If no ECMO 
is available, early consultation of an ECMO centre is 
recommended because transporting patients who need 
ECMO can be hazardous (strong agreement).
All aspects of ECMO in paediatric ARF are discussed 
in a Statement paper [86].
Setting the ventilator
Triggering
We recommend targeted patient ventilator synchrony in 
any triggered (non-invasive) positive pressure ventilation 
(strong agreement).
The effects of patient-ventilator asynchrony or inter-
ventions such as flow cycling on outcome are unclear 
[87–89]. However, better patient ventilator synchrony 
has been shown to improve patient comfort [89–92].
Setting the I:E ratio/inspiratory time
We recommend setting the inspiratory time and respira-
tory rate related to respiratory system mechanics and 
disease trajectory. Both are closely correlated and can-
not be judged as independent from each other (strong 
agreement). In restrictive lung disease, we recommend a 
higher respiratory rate to compensate for low tidal vol-
ume and maintain minute ventilation (strong agreement).
There are no outcome data to guide the choice of 
inspiratory time or I:E ratio. However, the time con-
stant (i.e. compliance times resistance) of the respiratory 
system (π) is an important parameter in this context. 
At the bedside, we suggest to avoid flow end-inspira-
tory or expiratory flow interruption, the latter to avoid 
air-trapping.
Maintaining spontaneous breathing
We recommend that all children on respiratory sup-
port preferably should breathe spontaneously, with the 
exception of the most severely ill child with obstructive 
airway (strong agreement), restrictive (strong agree-
ment) or mixed disease (strong agreement) requiring 
very high ventilator settings and intermittent neuromus-
cular blockade (strong agreement). In these children, 
controlled mechanical ventilation (pressure or volume) 
should be preferred, mandating the need for continuous 
sedation and/or muscle relaxants (strong agreement). 
Caution is advised when using sedation and relaxation in 
the presence of cardiac dysfunction (strong agreement).
Although there are no data to recommend on main-
taining spontaneous breathing, adult data suggest that 
maintaining spontaneous breathing during MV allows 
for a more homogeneous lung aeration and reduced risk 
of muscular atrophy and diaphragmatic dysfunction [93–
97]. In adults, 48-h use of neuromuscular blocking agents 
(NMBA) in early severe ARDS significantly reduced 
90-day crude mortality [98]. The only paediatric uncon-
trolled study on NMBA showed improved oxygenation 
[99]. No outcome data are available.
Setting the pressures
In the absence of transpulmonary pressure measure-
ments, we recommend limiting the plateau pressure 
(Plat) ≤28 cmH2O (87% agreement) or ≤29–32 cmH2O 
if the chest wall elastance is increased in restrictive 
lung disease (93% agreement), mixed disease (strong 
agreement) and children with congenital/chronic dis-
orders (strong agreement). We recommend limiting 
Pplat ≤30  cmH2O in obstructive airway disease (strong 
agreement).
Observational studies in (severe) lung injury identified 
a direct relationship between peak inspiratory pressure 
(PIP) and mortality [100–103]. Measuring transpulmo-
nary pressure (Ptp) instead of airway pressure (Paw) bet-
ter defines lung strain in (severe) lung injury, especially in 
the presence of increased chest wall elastance [104, 105]. 
However, there are no studies identifying upper limits 
for PIP, Pplat or Ptp. For severe disease, we recommend 
adhering to the Pediatric Acute Lung Injury Consensus 
Conference (PALICC) recommendations [106].
We recommend delta pressure (i.e. the difference 
between end inspiratory and end expiratory pressure) 
<10 cmH2O if there is no lung pathology (strong agree-
ment). There are no data to recommend any acceptable 
delta pressure in restrictive (strong agreement), obstruc-
tive airway (strong agreement) or mixed disease (strong 
agreement). For children with reduced lung volumes, the 
driving pressure at zero-flow (Vt/Crs) may dictate the 
optimal tidal volume (Vt) (strong agreement).
Driving pressure (ΔP = Vt/Crs) best stratified the risk 
for mortality in adults with ARDS [107]. These observa-
tions have not been replicated in children except for one 
study reporting an independent association between the 
airway pressure gradient (difference between PIP and 
PEEP) and mortality measured under dynamic flow con-
ditions [103].
Setting tidal volume
There are no data to recommend optimal Vt in restric-
tive (strong agreement), obstructive airway (strong 
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agreement), mixed disease (strong agreement), in cardiac 
children (strong agreement), children with congenital 
disorders or chronic ventilation (strong agreement. We 
recommend targeting physiologic Vt (strong agreement) 
and to avoid Vt  >  10  mL/kg ideal bodyweight (strong 
agreement). In children with lung hypoplasia syndromes, 
optimal Vt may be smaller than physiologic because of 
the lower lung volumes (strong agreement).
So far, not a single value of Vt has been associated with 
mortality in children, irrespective of disease severity (i.e. 
ALI/ARDS vs. non-ALI/ARDS) [108, 109]. Interestingly, 
some observational studies reported better outcomes 
for children who were ventilated with Vt   >  5–8  ml/kg 
and only one identified lower mortality associated with 
Vt ~8 mL/kg actual bodyweight compared with ~10 mL/
kg [100, 101, 110–112].
Setting PEEP
We recommend PEEP to prevent alveolar collapse. How-
ever, we cannot recommend how much PEEP should 
be used. Physiological data in children without lung 
injury suggests 3–5  cmH2O (strong agreement). In 
severe disease, high PEEP may be needed (strong agree-
ment). PEEP should always be set finding the optimal 
balance between haemodynamics and oxygenation. In 
order to improve oxygenation, PEEP titration should be 
attempted. There is no defined method to set best PEEP 
(strong agreement).
Moderate PEEP is sufficient when there is no lung 
pathology, but higher PEEP to restore EELV and improve 
respiratory system compliance (Crs) may be necessary in 
more severe disease and does not impair haemodynam-
ics [1, 113–121]. There are no data comparing low versus 
high PEEP in (severe) lung injury. Also, it is unclear how 
to set PEEP and whether markers such as  PaO2 or quasi-
static Crs predict best PEEP [122].
In obstructive airway or mixed disease, there are no 
data to recommend the level of PEEP in sedated and/or 
paralysed children who have sufficient expiratory times. 
However, assessment of intrinsic PEEP and Pplat may 
guide setting external PEEP in children with air trap-
ping who are mechanically ventilated and sedated (strong 
agreement). A balance needs to be found between alve-
olar recruitment and alveolar overdistension (strong 
agreement).
There are no data supporting external PEEP to attenu-
ate gas-trapping by splinting the airways open or guiding 
the allowable amount of external PEEP to facilitate spon-
taneous breathing [123–126].
We recommend using high PEEP to stabilise airways in 
ventilated children with trachea- and/or bronchomalacia. 
Careful titration of PEEP is mandated to avoid cardiovas-
cular compromise (strong agreement).
Observational data suggested reduced respiratory 
efforts with PEEP or CPAP in children with upper air-
way collapse. If used, it should be lowly titrated to avoid 
hemodynamic compromise [127, 128].
Lung recruitment
There are insufficient data to recommend any lung 
recruitment manoeuvre in children with (strong agree-
ment) or without (strong agreement) lung injury or in 
cardiac children (strong agreement).
Recruitment manoeuvres (RM) may resolve atelectasis 
and improve gas exchange, but there are no data show-
ing improved outcome [129–136]. There are no outcome 
data to recommend on the best RM (i.e. sustained infla-
tion or PEEP titration) [115, 137–139]. There is no indi-
cation for routine RMs after endotracheal suctioning 
[140].
Monitoring
Recommendations and long text on monitoring can be 
found in the ESM.
Targets for oxygenation and ventilation
Oxygenation
We cannot recommend a specific lower or upper limit for 
 SpO2 for any ventilated non-cardiac child with obstruc-
tive airway, restrictive or mixed disease (strong agree-
ment).  SpO2 >95% at room air should be expected in 
children without lung injury and extra-pulmonary mani-
festations (strong agreement). We recommend adhering 
to the PALICC guidelines for PARDS (i.e.  SpO2 92–97% 
when PEEP <10 cmH2O and 88–92% when PEEP ≥10  ) 
(strong agreement). We cannot recommend a specific 
upper or lower limit for  SpO2 for cardiac children. In 
children with cardiorespiratory failure, oxygen therapy 
should be titrated, balancing pulmonary disease against 
the underlying cardiac disorder, as well as in some con-
ditions (e.g., single ventricle physiology) balancing pul-
monary versus systemic blood flow (strong agreement). 
Increasing  FiO2 up to 1.0 in life-threatening acute pul-
monary hypertension crisis may be required (strong 
agreement).
There are no studies identifying the optimal  SpO2 range 
in the presence or absence of lung injury. In healthy chil-
dren breathing room air,  SpO2 >95% and  PaO2 between 
80 and 100  mmHg should be expected [141, 142]. In 
cardiac children, children with or at risk for lung injury 
or children with pulmonary hypertension, target  SpO2 
depends on the type and severity of laesions [143, 144]. 
PALICC proposed  SpO2 between 92 and 97% when 
PEEP <10  cmH2O and 88–92% for PEEP ≥10  cmH2O 
in non-cardiac PARDS [106]. There are no data report-
ing the safety and necessity of liberal or restrictive oxygen 
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therapy, but as a rule of thumb the lowest  FiO2 should be 
targeted [145–147].
Ventilation
We recommend achieving normal  CO2 levels in chil-
dren with normal lungs (strong agreement). For acute 
(non-)pulmonary children, higher levels of  CO2 may be 
accepted unless specific disease conditions dictate oth-
erwise. However, we cannot recommend any specific pH 
limit. We recommend permissive hypercapnia targeting 
a pH  >  7.20 (strong agreement). In children at risk for 
pulmonary hypertension, we recommend to maintain 
normal pH (strong agreement). We recommend using 
pH as non-pharmacologic tool to modify pulmonary vas-
cular resistance for specific disease conditions (strong 
agreement).
There are no studies identifying optimal  CO2 in the 
presence or absence of lung injury. Normal  CO2 levels 
(i.e. 35–45 mmHg) should be expected in healthy chil-
dren. Increasing ventilator settings in an attempt to 
normalise mild hypercapnia may be detrimental [148]. 
There are no outcome data on the effects of permis-
sive hypercapnia or the lowest tolerable pH [149, 150]. 
Normal pH and  PCO2 should be targeted in severe trau-
matic brain injury and pulmonary hypertension.
Weaning and extubation readiness testing
There are insufficient data to recommend on the timing 
of initiation (strong agreement) and approach to weaning 
(strong agreement) and the routine use of any extubation 
readiness testing that is superior to clinical judgement 
(strong agreement).
Assessing daily weaning readiness may reduce duration 
of ventilation [150–152]. There are no data supporting 
superiority of any approach such as protocolised weaning, 
closed-loop protocols, nurse-led weaning, or the useful-
ness of predictors for weaning success [123, 151, 153–172]. 
There are no data to recommend how to perform and eval-
uate extubation readiness testing (ERT), although some 
studies suggest that using a minimum pressure support 
overestimates extubation success [173–175].
There are insufficient data to recommend the routine 
use of non-invasive respiratory support after extubation 
for any patient category. However, early application of 
NIV combined with cough-assist techniques should be 
considered in neuromuscular diseases to prevent extuba-
tion failure (strong agreement).
There is only one small pilot study suggesting that 
the use of NIV may prevent reintubation in children at 
high-risk for extubation failure [42]. Although appealing, 
post-extubation NIV in combination with cough-assist 
techniques has not been confirmed to prevent extubation 
failure in neuromuscular patients yet [176–179].
Supportive measures
Humidification, suctioning, positioning and chest 
physiotherapy
We recommend airway humidification in ventilated chil-
dren, but there are insufficient data to recommend any 
type of humidification (strong agreement).
There are no data showing superiority or inferiority of 
either active or passive humidification [180–182]. How-
ever, there is great variability amongst commercially 
available HMEs regarding humidification efficacy, dead 
space volumes and imposed work of breathing [183].
There are insufficient data to recommend on the 
approach to endotracheal suctioning (strong agreement), 
but the likelihood of derecruitment during suctioning 
needs to be minimised (strong agreement). The routine 
instillation of isotonic saline prior to endotracheal suc-
tioning is not recommended (strong agreement).
There is no scientific basis for routine endotracheal 
suctioning or the approach to suctioning (open vs. 
closed) albeit that open suctioning may lead to more 
derecruitment or the instillation of isotonic saline prior 
to suctioning [140, 184–188].
There are insufficient data to recommend chest physi-
otherapy as a standard of care (strong agreement). Use 
of cough-assist techniques should be considered for 
patients with neuromuscular disease on NIV to prevent 
failure (strong agreement).
Chest physiotherapy for airway clearance and sputum 
evacuation cannot be considered standard of care [189, 
190]. It is unclear whether cough-assist techniques add 
any value to patients with neuromuscular disease who 
require NIV, but their use should be considered to pre-
vent endotracheal intubation [176, 178, 191–195].
We recommend that all children should be main-
tained with the head of the bed elevated to 30–45°, unless 
specific disease conditions dictate otherwise (strong 
agreement).
Endotracheal tube and patient circuit
Endotracheal high-volume low-pressure cuffed tubes can 
be used in all children. Meticulous attention to cuff pres-
sure monitoring is indicated (strong agreement).
Cuffed ETTs can be safely used without increased risk 
for post-extubation stridor when the cuff pressure is 
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maintained ≤20 cmH2O [196, 197]. Cuff pressure moni-
toring has to be routinely performed using cuff-specific 
devices [198].
Dead space apparatus should be reduced as much as 
possible by using appropriate patient circuits and reduc-
tion of swivels (strong agreement).
Any component that is added after the Y piece 
increases dead space and may have clinical relevance 
[199].
Double-limb circuits should be used for invasive ven-
tilation (strong agreement), and preferentially a single-
limb circuit for NIV (93% agreement).
Single-limb circuits are very sensitive to leaks [200]. 
Therefore, single-limb home ventilators are not suitable 
for invasive ventilation in the PICU [201].
Miscellaneous
We recommend avoiding routine use of hand-ventilation. 
If needed, pressure measurements and pressure pop-off 
valves should be used (strong agreement).
Manual ventilation should be avoided to prevent the 




Recommendations for children with acute restrictive, 
obstructive or mixed disease should also be applied to 
children with lung hypoplasia syndromes who suffer 
from acute deterioration (strong agreement).
Chronically ventilated/congenital patient
In severe or progressive underlying disease, we recom-
mend considering whether or not invasive ventilation 
is beneficial for the particular child (strong agreement). 
For chronic neuromuscular children and other children 
on chronic ventilation with acute deterioration, the same 
recommendations as for children with normal lungs, 
acute restrictive, acute obstructive or mixed disease are 
applicable (strong agreement). Preservation of sponta-
neous breathing should be aimed for in these children 
(strong agreement).
Invasive ventilation may be life-saving, but the risk/
benefit ratio should be carefully evaluated in each venti-
lator-dependent child who suffers from acute exacerba-
tions or in children with life-limiting congenital disorders 
[203–208]. In the absence of data, we suggest that the 
recommendations for children with acute restrictive, 
obstructive or mixed disease are also applicable in this 
patient category.
Cardiac children
Positive pressure ventilation may reduce work of breath-
ing and afterload in LV failure, but it may increase after-
load in RV failure (strong agreement). In cardiac children 
with or without lung disease, the principles for any spe-
cific pathology will apply, but titration of ventilator set-
tings should be carried out even more carefully (strong 
agreement). We cannot recommend on a specific level 
of PEEP in cardiac children with or without lung disease, 
irrespective of whether or not there is increased pulmo-
nary blood flow, but sufficient PEEP should be used to 
maintain end-expiratory lung volume (strong agreement).
Many of the assumptions on cardiopulmonary interac-
tions in children are mainly based on adult data [209–212]. 
For cardiac children, assisted rather than controlled venti-
lation may be preferable [57, 59]. However, in patients with 
passive pulmonary blood flow, spontaneous breathing 
on CPAP 3 5  cmH2O reduced FRC and increased PVRI, 
whereas MV with PEEP 3–5 cmH2O did not [213]. Neither 
CPAP nor PEEP ≤15 cmH2O impaired venous return or 
cardiac output after cardiac surgery [214–217]. This means 
that, for cardiac children, the same principles for MV apply 
as for non-cardiac children [211, 218].
Reflecting on the consensus conference
Our consensus conference has clearly but also painfully 
emphasised that there is very little, if any, scientific evi-
dence supporting our current approach to paediatric 
mechanical ventilation (Fig.  1; Tables  1, 2). Given this 
absence of evidence, our recommendations reflect a con-
sensus on a specific topic that we agreed upon. To date, 
most of what we do is either based on personal experi-
ences or how it works in adults. In fact, when it comes 
to paediatric MV “each paediatric critical care practi-
tioner is a maven and savant and knows the only correct 
way to ventilate a child” (by Christopher Newth). This 
lack of scientific background should challenge everybody 
involved in paediatric mechanical ventilation to embark 
on local or global initiatives to fill this huge gap of knowl-
edge. We are in desperate need of well-designed studies 
and must constantly remind us that “Anecdotes” are not 
plural for “Evidence” [219–221]. This European paediat-
ric mechanical ventilation consensus conference is a first 
step towards a better and substantiated use of this life-
saving technique in critically ill children (Figs. 2, 3, 4).    
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Table 1 Overview of published literature related to all aspects of paediatric mechanical ventilation for the disease condi-
tions discussed in the consensus conference
Subject Available data Applicability to specific disease conditions
RCT Observational
Non‑invasive support
 Use of HFNC None Yes Healthy lungs, all disease conditions
 Use of CPAP None Yes All disease conditions
 Non‑invasive ventilation Yes (n = 2) Yes All disease conditions
Ventilator modes
 Conventional modes None Yes Healthy lungs, all disease conditions
 HFOV Yes (n = 2) Yes All disease conditions
 HFJV, HFPV No Yes All disease conditions
 Liquid ventilation No No All disease conditions
 ECMO No Yes All disease conditions
Setting the ventilator
 Patient‑ventilator synchrony No Yes All disease conditions
 I:E ratio/inspiratory time No No All disease conditions
 Maintaining spontaneous breathing No No Healthy lungs, all disease conditions
 Plateau pressure No No Healthy lungs, all disease conditions
 Delta pressure/driving pressure No No Healthy lungs, all disease conditions
 Tidal volume No Yes Healthy lungs, all disease conditions
 PEEP No Yes Healthy lungs, all disease conditions, upper airway disorders
 Lung recruitment No Yes Healthy lungs, all disease conditions
Monitoring
 Ventilation No Yes Healthy lungs, all disease conditions
 Oxygenation No Yes Healthy lungs, all disease conditions
 Tidal volume No Yes Healthy lungs, all disease conditions
 Lung mechanics No Yes Healthy lungs, all disease conditions
 Lung ultrasound No Yes All disease conditions
Targets for oxygenation and ventilation
 Oxygenation No No Healthy lungs, all disease conditions
 Ventilation No No Healthy lungs, all disease conditions
Weaning and extubation readiness testing
 Weaning Yes (n = 2) Yes Healthy lungs, all disease conditions
 NIV after extubation No Yes All disease conditions
 Use of corticosteroids Yes Yes Healthy lungs, all disease conditions
Supportive measures
 Humidification No Yes Healthy lungs, all disease conditions
 Endotracheal suctioning No Yes Healthy lungs, all disease conditions
 Chest physiotherapy No Yes All disease conditions
 Bed head elevation No No Healthy lungs, all disease conditions
 ETT and patient circuit No Yes Healthy lungs, all disease conditions
 Reducing dead space apparatus No Yes Healthy lungs, all disease conditions
 Heliox No Yes Obstructive airway disease
 Use of manual ventilation No No Healthy lungs, all disease conditions
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Table 2 Potential clinical implications of the recommendations from the paediatric mechanical ventilation consensus 
conference (PEMVECC)
Non‑invasive support
 High‑flow nasal cannula No recommendation
 Continuous positive airway pressure Consider in mixed disease
Consider in mild‑to‑moderate cardiorespiratory failure
No recommendation on optimal interface
 Non‑invasive ventilation Consider in mild‑to‑moderate disease, but not severe disease
Consider in mild‑to‑moderate cardiorespiratory failure
Should not delay intubation
No recommendation on optimal interface
Invasive ventilation
 Mode No recommendation
 High‑frequency oscillatory ventilation Consider when conventional ventilation fails
May be used in cardiac patients
 High‑frequency jet/percussive ventilation No recommendation
Do not use high‑frequency jet ventilation in obstructive airway disease
 Liquid ventilation Do not use
 Extra‑corporeal life support Consider in reversible disease if conventional ventilation and/or HFOV fails
 Triggering Target patient‑ventilator synchrony
 Inspiratory time/I:E ratio Set inspiratory time by respiratory system mechanics and underlying disease (use time constant and 
observe flow‑time scalar). Use higher rates in restrictive disease
 Maintaining spontaneous breathing No recommendation
 Plateau pressure Keep ≤28 or ≤29–32 cmH2O with increased chest wall elastance, ≤30 cmH2O in obstructive airway 
disease
 Delta pressure Keep ≤10 cmH2O for healthy lungs, unknown for any disease condition
 Tidal volume Keep ≤10 mL/kg ideal bodyweight, maybe lower in lung hypoplasia syndromes
 PEEP 5−8 cmH2O, higher PEEP necessary dictated by underlying disease severity (also in cardiac patients)
Use PEEP titration, consider lung recruitment (also in cardiac patients)
Add PEEP in obstructive airway disease when there is air‑trapping and to facilitate triggering
Use PEEP to stent upper airways in case of malacia
Monitoring
 Ventilation Measure  PCO2 in arterial or capillary blood samples
Consider transcutaneous  CO2 monitoring
Measure end‑tidal  CO2 in all ventilated children
 Oxygenation Measure  SpO2 in all ventilated children
Measure arterial  PO2 in moderate‑to‑severe disease
Measure pH, lactate and central venous saturation in moderate‑to‑severe disease
Measure central venous saturation as marker for cardiac output
 Tidal volume Measure near Y‑piece of patient circuit in children <10 kg
 Lung mechanics Measure peak inspiratory pressure and/or plateau pressure, mean airway pressure, positive end‑expiratory 
pressure. Consider measuring transpulmonary pressure, (dynamic) compliance, intrinsic PEEP
Monitor pressure–time and flow‑time scalar
 Lung ultrasound Consider in appropriately trained hands
Targets
 Oxygenation SpO2 ≥ 95% when breathing room air for healthy lungs
No threshold for any disease condition or cardiac patients, but keep  SpO2 ≤97%
For PARDS:  SpO2 92–97% when PEEP < 10cmH2O and 88–92% when PEEP ≥10  cmH2O
 Ventilation PCO2 35–45 mmHg for healthy lungs
Higher  PCO2 accepted for acute (non‑)pulmonary patients unless specific diseases dictate otherwise
Target pH >7.20
Target normal pH for patients with pulmonary hypertension
Weaning and extubation readiness
 Weaning Start weaning as soon as possible
Perform daily extubation readiness testing
 Non‑invasive ventilation after extubation Consider non‑invasive ventilation in neuromuscular patients




 Humidification Use humidification
 Endotracheal suctioning Do not perform routinely, only on indication. No routine instillation of isotonic saline prior to suctioning
 Chest physiotherapy Do not use routinely
Consider using cough‑assist devices in neuromuscular patients
 Positioning Maintain head of bed elevated 30–45°
 Endotracheal tube and patient circuit Use cuffed endotracheal tube, keep cuff pressure ≤20 cmH2O
Minimise dead space by added components
Use double‑limb circuits for invasive ventilation
Do not use home ventilators during the acute phase in the intensive care unit
Miscellanenous
 Hand‑ventilation Avoid hand ventilation unless specific conditions dictate otherwise
Healthy lungs
Mild Moderate Severe 


















Tidal volume 5 - 7 mL/kg in the physiologic range 
Restrictive disease Obstructive airway disease




Non-invasive ventilation Non-invasive ventilation




Consider lung recruitment Consider lung recruitment
HFOV
ECLS ECLS
Higher PEEP Higher PEEP 
Consider NMB Consider NMB
HFNC
Fig. 2 Graphical simplification of the recommendations on “ventilator mode”, “setting the ventilator” and “supportive measures” in the context of 
healthy lungs, obstructive airway, restrictive and mixed disease. It is also applicable for cardiac patients, patients with congenital of chronic disease 
and patients with lung hypoplasia syndromes. The colour gradient denotes increasing applicability of a specific consideration with increasing 
disease severity. Absence of the colour gradient indicates that there is no relationship with disease severity. The question mark associated with specific 
interventions highlights the uncertainties because of the lack of paediatric data. HFNC high flow nasal cannula, CPAP continuous positive airway 
pressure, NIV non‑invasive ventilation, PIP peak inspiratory pressure, Pplat plateau pressure, Vt tidal volume, PEEP positive end‑expiratory pressure, 
HFOV high‑frequency oscillatory ventilation, ECLS extra‑corporeal life support, NMB neuromuscular blockade
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Fig. 3 Graphical simplification of the recommendations on “monitor‑
ing” in the context of healthy lungs, obstructive airway, restrictive 
and mixed disease. It is also applicable for cardiac patients, patients 
with congenital of chronic disease and patients with lung hypoplasia 
syndromes. The colour gradient denotes increasing applicability of 
a specific consideration with increasing disease severity. Absence of 
the colour gradient indicates that there is no relationship with disease 
severity. The question mark associated with specific interventions 
highlights the uncertainties because of the lack of paediatric data. PIP 
peak inspiratory pressure, Pplat plateau pressure, Vt tidal volume, PEEP 
positive end‑expiratory pressure, mPaw mean airway pressure, SvO2 
venous oxygen saturation
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SpO2> 95% Lower SpO2
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PALICC: SpO2 92-97% if PEEP <10 cmH2O
SpO2 88-92% if PEEP ≥10 cmH2O
Fig. 4 Graphical simplification of the recommendations on “targets 
of oxygenation and ventilation” in the context of healthy lungs, 
obstructive airway, restrictive and mixed disease. It is also applicable 
for cardiac patients, patients with congenital of chronic disease and 
patients with lung hypoplasia syndromes. The colour gradient denotes 
increasing applicability of a specific consideration with increasing dis‑
ease severity. Absence of the colour gradient indicates that there is no 
relationship with disease severity. The question mark associated with 
specific interventions highlights the uncertainties because of the 
lack of paediatric data. PALICC pediatric acute lung injury consensus 
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